Dec 07, 2023 / 04:30PM GMT
Mark Wilterding - Edwards Lifesciences Corporation - VP of IR
Thank you all for joining us. We appreciate it. We're really happy you're here, and thank you for taking the time to get to know Edwards a little bit more. We've got a great session for you both for those of you here in person as well as those of you joining us online, we're going to hear from a number of our senior management team.
We've got a number of physician cameos. You'll see our latest and greatest products as well as get updates on our clinical trials and our financial outlook. So with that, let me just flash up a couple of quick slides. I am Mark Wilterding, Head of Investor Relations for Edwards Lifesciences. As you know, the cautionary statement, at least take a minute to familiarize yourself with this. Very important. It's also available on our website, so you can take some time to read through that.
We will be referring to non-GAAP financials unless otherwise noted during the course of this presentation. Reconciliations to those non-GAAP financials are available on our website at ir.edwards.com. And with that,
Edwards Lifesciences Corp Investor Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers